EXICURE, INC. Increase (Decrease) in Deferred Charges
EXICURE, INC. (XCUR) reported Increase (Decrease) in Deferred Charges of $0 for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2018-05-15
- EXICURE, INC. increase (decrease) in deferred charges for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. increase (decrease) in deferred charges for the quarter ending 2017-03-31 was $241.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month |
|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 |
| 2017-03-31 | $241.00K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |